News
Recruitment for the FAIR PARK II study is now closed: The last patient has been enrolled on December 5th 2019
The FAIR-PARK II 6h annual meeting was held virtually on 22nd April 2021
The FAIR-PARK II 5th annual meeting was held in Paris, France on 26th June 2019.
The FAIR-PARK II 4th annual meeting was held in Lisbon, Portugal on 15th and 16th June 2018.
The FAIR-PARK II 3rd annual meeting was held in Amsterdam, Netherlands on 26th and 27th June 2017.
The FAIR-PARK II 2nd annual meeting was held in Berlin, Germany on 23-24 June 2016.
The FAIR-PARK II kick-off meeting was held in Lille, France on 4-5 May 2015.
Recruitment for the FAIR PARK II study is now open: The first patient has been enrolled in Lille's hospital on February 9th 2016
The final list of European expert centres for the clinical trial is available since October 2015.
The final version of the protocol, as released by competent authorities and ethic national committees is available since january 2016
Patient Recruitment Countdown
16th December 2019
Patients to be recruited
0
Patients recruited
372
The recruitment is now closed
Evžen Růžička is a Professor and Chairman in the Department of Neurology, Charles University, Prague, Czech Republic. He obtained his neurological training at the university departments of neurology in Prague and at La Salpetriere, Paris, France. He has edited or co-edited several books including the Gait Disorders volume of Advances in Neurology, and has published original articles covering Parkinson’s disease and other movement disorders. In 2015, Dr. Růžička was elected Chair-Elect of the European Section of the Movement Disorders Society.
Prof. Daniela Berg is Director at the Centre of Neurology, Campus KIEL, Christian-Albrechts Universität, Germany.
The General Assembly is the project's main decision-making body, it is responsible for the project's strategic and political policy and any amendments in terms of the work plan, budget and partnership.
| Participant No. | Organisation Name | Short Name | Name | Image |
|---|---|---|---|---|
| 1 (Coordinator): Chairman | Centre Hospitalier Regional et Universitaire de Lille | CHRUL | David Devos |  |
| 2a | Institut National de la Santé et de la Recherche Médicale | INSERM | Jean-Christophe Corvol |  |
| 2b | Institut National de la Santé et de la Recherche Médicale |
INSERM F-CRIN |
Olivier Rascol |  |
| 3 | European Clinical Research Infrastructure Network | ECRIN | Amélie Michon |  |
| 4 | INSERM - Transfert SA | IT | Delphine Smagghe |  |
| 5 | Apo-Pharma inc. | APOPHARMA | Michael Spino | - |
| 6 | Instituto de Medicina Molecular | IMM | Joaquim Ferreira |  |
| 7 | Fundació privada Clínic per a la Recerca Biomèdica | FCRB | Yaroslau Compta | |
| 8 | University of Newcastle upon Tyne | UNEW | Nicola Pavese | |
| 10 | Medizinische Universitat Innsbruck | MUI | Werner Poewe |  |
| 11 | Univerzita Karlova v Praze | CUP | Evžen Růžička |  |
| 12 | Stichting Katholieke Universiteit | RUNMC | Bart Post |  |
| 13 | Philipps Universitat Marburg | PUM | Richard Dodel |  |
| 14 | Université Pierre et Marie Curie | UPMC | Marie-Odile Habert | - |
| 15 | Universitaet Ulm | UULM | Markus Otto | - |
| 16 | Christian-Albrechts Universität | CAU | Daniela Berg |  |
The Scientific Advisory Board of FAIR-PARK II is an independent body and is composed of internationally renowned scientists. It provides independent advice on (i) managing the project and maximizing the latter's scientific, technological and health-related impact and (ii) exploitation the most promising results.
| Title | Name | Organisation | Country |
|---|---|---|---|
| Prof | Ioav Cabantchik | Hebrew University | Israel |
| Prof | Christian Rose (Deceased) | Hopital Saint-Vincent-de-Paul | France |
| Prof | Regis Bordet | Université Lille 2 | France |
| Prof | David Dexter | Imperial College London | UK |
| Prof | Nir Giladi | Tel Aviv Sourasky Medical Center | Israel |
| Prof | Dag Nyholm | Uppsala University | Sweden |
| Prof | Giovanni Abbruzzese | University of Genove | Italy |
| Prof | Paolo Barone | University of Salerno | Italy |
| Dr | Jean-Christophe Devedjian | Université Lille 2 | France |
| Dr | Nadine Le Forestier | Assistance Publique – Hôpitaux de Paris | France |
| Prof | Ashley Bush | The Florey Institute of neuroscience and Mental Health | Australia |
| Dr | James Duce | University of Leeds | UK |
The Innovation Management Board will ensure that:
- the Intellectual Property provisions of the FAIR-PARK II Consortium Agreement are adhered to throughout the project,
- appropriate forms of Intellectual Property protection are sought,
- the consortium members receive support in drawing up project exploitation plans.
The Innovation Management Board will be composed of technology transfer officers from each partner organisation of FAIR-PARK II:
| Participant N° | Participant organisation name | Short Name | Name |
|---|---|---|---|
|
1 |
Centre Hospitalier Regional et Universitaire de Lille |
CHRUL |
Marie-Anne ALLAIN |
|
2a |
Institut National de la Santé et de la Recherche Médicale |
INSERM |
Jean-Christophe Corvol |
|
2b |
Institut National de la Santé et de la Recherche Médicale |
INSERM |
Olivier Rascol |
|
3 |
European Clinical Research Infrastructure Network |
ECRIN |
Jacques Demotes |
|
4 (Chairman) |
Inserm Transfert |
IT |
Denise Hirsch |
|
5 |
Apo-Pharma Inc. |
APOPHARMA |
Michael Spino |
|
6 |
Instituto de Medicina Molecular |
IMM |
Joaquim Ferreira |
|
7 |
Fundació privada Clínic per a la Recerca Biomèdica |
FCRB |
Eduardo Tolosa |
|
8 |
University of Newcastle upon Tyne |
UNEW |
David Burn |
|
9 |
Eberhard Karls Universitaet Tuebingen |
EKUT |
Holm Graessner |
|
10 |
Medizinische Universitat Innsbruck |
MUI |
Werner Poewe |
|
11 |
Univerzita Karlova v Praze |
CUP |
Evžen Růžička |
|
12 |
Stichting Katholieke Universiteit |
RUNMC |
Martijn Bakker |
|
13 |
Philipps Universitat Marburg |
PUM |
Dr. Sandra Basenau |
|
14 |
Université Pierre et Marie Curie |
UPMC |
Marie-Odile Habert |
|
15 |
Universitaet Ulm |
UULM |
Markus Otto |
| 16 | Christian-Albrechts-Universitaet | CAU | Daniela Berg |
Form 1
Form 2
Form 3
Form 4
FAIR PARK II
Conservative iron chelation as a disease modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomised clinical trial of deferiprone
Latest News Articles
Navigation
Contact Us
People
Scientific Coordinator: Prof David Devos
Project Manager (CHRUL): Pauline Guyon [email protected]
Senior Project Manager (IT): Delphine Smagghe [email protected]
Project Manager (IT): Stephanie Le Naour [email protected]
Addresses
Centre Hospitalier Regional et Universitaire de Lille (CHRUL), 2 avenue Oscar Lambret - 59037 Lille Cedex
Inserm-Transfert (IT), 7 rue de Watt - 75013 Paris, France
Lille CHRUL
Paris Inserm Transfert
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633190.
© FAIRPARK II 2015